|
tbar.gif
Click
here to
submit entries
|
|
|
Fujifilm
Buying Toyama Chemical for $1.4B, Gaining Experimental Flu Drug |
February 19, 2008--Fujifilm
said it will buy 66% of Toyama Chemical Co. If approved, Toyama’s
experimental flu treatment T-705 may become a competitor to Roche’s
blockbuster flu drug Tamiflu (oseltamivir phosphate) within two years. Bloomberg.com
|
|
|
Genstruct: Patience, Persistence, and Payoff
By John Russell |
|
Finding the right business model for systems biology (SB) technology providers has been challenging — that’s hardly a new theme in biotech.
Click
here
|
|
|
